<SEC-DOCUMENT>0001193125-21-071538.txt : 20210305
<SEC-HEADER>0001193125-21-071538.hdr.sgml : 20210305
<ACCEPTANCE-DATETIME>20210305163108
ACCESSION NUMBER:		0001193125-21-071538
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210303
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210305
DATE AS OF CHANGE:		20210305

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AGILENT TECHNOLOGIES, INC.
		CENTRAL INDEX KEY:			0001090872
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				770518772
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15405
		FILM NUMBER:		21718890

	BUSINESS ADDRESS:	
		STREET 1:		5301 STEVENS CREEK BLVD
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95051
		BUSINESS PHONE:		(408) 345-8886

	MAIL ADDRESS:	
		STREET 1:		5301 STEVENS CREEK BLVD, MS 1A-LC
		STREET 2:		P.O. BOX 58059
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95052-8059

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AGILENT TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19990816

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HP MEASUREMENT INC
		DATE OF NAME CHANGE:	19990716
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d147637d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:a="http://www.agilent.com/20210303" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2021-03-03_to_2021-03-03">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2021-03-03_to_2021-03-03">0001090872</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="a-20210303.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2021-03-03_to_2021-03-03"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001090872</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-03-03</xbrli:startDate> <xbrli:endDate>2021-03-03</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2021-03-03_to_2021-03-03">8-K</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2021-03-03_to_2021-03-03" format="ixt:datemonthdayyearen">March 3, 2021</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2021-03-03_to_2021-03-03">AGILENT TECHNOLOGIES, INC.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2021-03-03_to_2021-03-03" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2021-03-03_to_2021-03-03">001-15405</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2021-03-03_to_2021-03-03">77-0518772</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2021-03-03_to_2021-03-03">5301 Stevens Creek Boulevard</ix:nonNumeric>,</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2021-03-03_to_2021-03-03">Santa Clara</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2021-03-03_to_2021-03-03">CA</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2021-03-03_to_2021-03-03">95051</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2021-03-03_to_2021-03-03">(800)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2021-03-03_to_2021-03-03">227-9770</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2021-03-03_to_2021-03-03" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2021-03-03_to_2021-03-03" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2021-03-03_to_2021-03-03" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2021-03-03_to_2021-03-03" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-03-03_to_2021-03-03">Common Stock, $0.01 Par Value</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-03-03_to_2021-03-03">A</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-03-03_to_2021-03-03" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter) <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2021-03-03_to_2021-03-03" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric>.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;8.01. Other Events. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;3, 2021, Agilent Technologies,&#160;Inc.&#160;(the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Barclays Capital Inc., Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein (the &#8220;Underwriters&#8221;), pursuant to which the Company agreed to issue and sell to the Underwriters $850&#160;million in aggregate principal amount of its 2.300% Senior Notes due 2031 (the &#8220;Notes&#8221;) in an underwritten public offering (the &#8220;Offering&#8221;).&#160;The Offering is expected to close on March&#160;12, 2021, subject to customary closing conditions. The Underwriting Agreement contains customary representations and covenants and includes the terms and conditions of the sale of the Notes, indemnification and contribution obligations and other terms and conditions customary in agreements of this type. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes will be issued pursuant to a base indenture, expected to be dated as of March&#160;12, 2021, between the Company and Citibank, N.A., as trustee (the &#8220;Trustee&#8221;), as supplemented by a first supplemental indenture thereto, expected to be dated as of&#160;March 12, 2021, between the Company and the Trustee. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes will be issued at a price to the public of 99.822% of their principal amount.&#160;The Notes will mature on March&#160;12, 2031 and bear interest at a fixed rate of 2.300% per annum, payable semi-annually in arrears on March&#160;12 and September&#160;12 of each year, commencing on September&#160;12, 2021. The Notes will be unsecured and will rank equally in right of payment with all of the Company&#8217;s other senior unsecured indebtedness. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are being offered pursuant to the Company&#8217;s Registration Statement on <span style="white-space:nowrap">Form&#160;S-3</span> (File <span style="white-space:nowrap">No.&#160;333-233593)</span> filed with the Securities and Exchange Commission on September&#160;3, 2019, as supplemented by the prospectus supplement, dated March&#160;3, 2021. In connection with the Offering, the Company is filing the Underwriting Agreement as Exhibit&#160;No.&#160;1.1 to this Current Report on <span style="white-space:nowrap">Form&#160;8-K.</span> The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to such exhibit. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of the legal opinion of Goodwin Procter LLP relating to the legality of the issuance and sale of the Notes in the Offering is attached as Exhibit 5.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;3, 2021, the Company issued a press release announcing the pricing of the Offering. A copy of the press release is filed as Exhibit&#160;99.1 to this Current Report on <span style="white-space:nowrap">Form&#160;8-K</span> and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March 5, 2021, the Company elected to call for full redemption of its $300&#160;million outstanding 3.20% Senior Notes due September 2022 (the &#8220;2022 Notes&#8221;) and a notice of redemption has been sent to all registered holders of the 2022 Notes. The redemption price for the 2022 Notes is equal to the present value of the remaining scheduled principal and interest payments on the notes (excluding interest accrued to, but not including, the redemption date), as determined in accordance with the supplemental indenture relating to the 2022 Notes, on the third business day prior to the redemption date, plus accrued and unpaid interest to, but excluding, April 5, 2021, which is the date of redemption. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#160;9.01. Financial Statements and Exhibits. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)&#160;Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Exhibit<br />No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d147637dex11.htm">Underwriting Agreement, dated March&#160;3, 2021, by and among the Company, Barclays Capital Inc., Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as representatives of the several Underwriters </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d147637dex51.htm">Opinion of Goodwin Procter LLP </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d147637dex51.htm">Consent of Goodwin Procter LLP (included in Exhibit 5.1). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d147637dex991.htm">Press Release, dated March&#160;3, 2021 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:12%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:87%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">AGILENT TECHNOLOGIES, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ P. Diana Chiu</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">P. Diana Chiu</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Assistant General Counsel</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">and Assistant Secretary</p></td></tr>
</table></div> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Date: March&#160;5, 2021 </p>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d147637dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGILENT TECHNOLOGIES, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">$850,000,000 2.300% Senior Notes due 2031 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Underwriting Agreement </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">March&nbsp;3, 2021 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc. and </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As Representatives of the </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">several Underwriters listed </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">in
Schedule 1 hereto </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c/o</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Barclays Capital Inc. </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">745 Seventh Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">New York, New
York 10019 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c/o</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Citigroup Global Markets Inc. </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">388 Greenwich Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">New York,
New York 10013 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c/o</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">J.P. Morgan Securities LLC </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">383 Madison Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">New York, New
York 10179 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Agilent
Technologies, Inc., a Delaware corporation (the &#147;Company&#148;), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the &#147;Underwriters&#148;), for whom you are acting as representatives (the
&#147;Representatives&#148;), $850&#044;000&#044;000 principal amount of its 2.300% Senior Notes due 2031 (the &#147;Securities&#148;).&nbsp;The Securities will be issued pursuant to the indenture to be dated as of March&nbsp;12, 2021 (the
&#147;Base Indenture&#148;) between the Company and Citibank, N.A., as trustee (the &#147;Trustee&#148;), as supplemented by the First Supplemental Indenture, to be dated as of March&nbsp;12, 2021, in respect of the Securities (the &#147;First
Supplemental Indenture&#148; and, together with the Base Indenture, the &#147;Indenture&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company hereby confirms its agreement
with the several Underwriters concerning the purchase and sale of the Securities, as follows:</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Registration Statement</U>.&nbsp;The
Company has prepared and filed with the Securities and Exchange Commission (the &#147;Commission&#148;) under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#147;Securities
Act&#148;), a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File No.&nbsp;333-233593), including a prospectus (the &#147;Basic Prospectus&#148;), relating to the debt securities, including the Securities, to be issued
from time to time by the Company.&nbsp;The Company has also filed, or proposes to file, with the Commission pursuant to Rule 424 under the Securities Act a prospectus supplement specifically relating to the Securities (the &#147;Prospectus
Supplement&#148;).&nbsp;The registration statement, as amended at the time it becomes effective, including the information, if any, deemed pursuant to Rule 430A, 430B or 430C under the Securities Act to be part of the registration statement at the
time of its effectiveness (&#147;Rule 430 Information&#148;), is referred to herein as the &#147;Registration Statement&#148;; and as used herein, the term &#147;Prospectus&#148; means the Basic Prospectus as supplemented by the prospectus
supplement specifically relating to the Securities in the form first used (or made available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection with confirmation of sales of the Securities and the term
&#147;Preliminary Prospectus&#148; means the preliminary prospectus supplement specifically relating to the Securities together with the Basic Prospectus.&nbsp;Any reference in this Agreement to the Registration Statement, the Basic Prospectus, any
Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
documents incorporated by reference therein pursuant to Item 12 of Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act, as of the effective date of the Registration
Statement or the date of such Preliminary Prospectus or the Prospectus, as the case may be, and any reference to &#147;amend&#148;, &#147;amendment&#148; or &#147;supplement&#148; with respect to the Registration Statement, any Preliminary
Prospectus or the Prospectus shall be deemed to refer to and include any documents filed after such date under the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder (collectively, the
&#147;Exchange Act&#148;) that are deemed to be incorporated by reference therein.&nbsp;Capitalized terms used but not defined herein shall have the meanings given to such terms in the Registration Statement and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At or prior to the time when sales of the Securities were first made (the &#147;Time of Sale&#148;), the Company had prepared the following
information (collectively, the &#147;Time of Sale Information&#148;): a Preliminary Prospectus dated March&nbsp;3, 2021, and each &#147;free-writing prospectus&#148; (as defined pursuant to Rule 405 under the Securities Act) listed on Annex A hereto
as constituting part of the Time of Sale Information. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Purchase of the Securities by the Underwriters</U>.&nbsp;(a)&nbsp;The Company
agrees to issue and sell the Securities to the several Underwriters as provided in this Agreement, and each Underwriter, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein,
agrees, severally and not jointly, to purchase from the Company the respective principal amount of Securities set forth opposite such Underwriter&#146;s name in Schedule 1 hereto at a price equal to 99.172% of the principal amount of the Securities
plus accrued interest, if any, from March&nbsp;12, 2021 to the Closing Date (as defined below).&nbsp;The Company will not be obligated to deliver any of the Securities except upon payment for all the Securities to be purchased as provided herein.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Company understands that the Underwriters intend to make a public offering of the Securities as soon after the effectiveness of
this Agreement as in the judgment of the Representatives is advisable, and initially to offer the Securities on the terms set forth in the Prospectus.&nbsp;The Company acknowledges and agrees that the Underwriters may offer and sell Securities to or
through any affiliate of an Underwriter and that any such affiliate may offer and sell Securities purchased by it to or through any Underwriter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Payment for and delivery of the Securities will be made at the offices of Simpson Thacher&nbsp;&amp; Bartlett LLP, 2475 Hanover Street,
Palo Alto, California 94304 at 10:00 A.M., New York City time, on March&nbsp;12, 2021, or at such other time or place on the same or such other date, not later than the fifth business day thereafter, as the Representatives and the Company may agree
upon in writing.&nbsp;The time and date of such payment and delivery is referred to herein as the &#147;Closing Date&#148;. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Payment
for the Securities shall be made by wire transfer in immediately available funds to the account(s) specified by the Company to the Representatives against delivery to the nominee of The Depository Trust Company, for the account of the Underwriters,
of one or more global notes representing the Securities (collectively, the &#147;Global Note&#148;), with any transfer taxes payable in connection with the sale of the Securities duly paid by the Company.&nbsp;The Global Note will be made available
for inspection by the Representatives not later than 1:00 P.M., New York City time, on the business day prior to the Closing Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The
Company acknowledges and agrees that the Underwriters are acting solely in the capacity of an arm&#146;s length contractual counterparty to the Company with respect to the offering of Securities contemplated hereby (including in connection with
determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person.&nbsp;Additionally, neither the Representatives nor any other Underwriter is advising the Company or any other
person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction.&nbsp;The Company shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and
appraisal of the transactions contemplated hereby, and the Underwriters shall have no responsibility or liability to the Company with respect thereto. Any review by the Underwriters of the Company, the transactions contemplated hereby or other
matters relating to such transactions will be performed solely for the benefit of the Underwriters and shall not be on behalf of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Representations and Warranties of the Company</U>.&nbsp;The Company represents and warrants to each Underwriter that: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Preliminary Prospectus</I>.&nbsp;No order preventing or suspending
the use of any Preliminary Prospectus has been issued by the Commission, and each Preliminary Prospectus, at the time of filing thereof, complied in all material respects with the Securities Act and did not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no
representation and warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives
expressly for use in any Preliminary Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Time of Sale Information</I>.&nbsp;The Time of Sale Information,
at the Time of Sale did not, and at the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they
were made, not misleading; <U>provided</U> that the Company makes no representation and warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the
Company in writing by such Underwriter through the Representatives expressly for use in such Time of Sale Information.&nbsp;No statement of material fact included in the Prospectus has been omitted from the Time of Sale Information and no statement
of material fact included in the Time of Sale Information that is required to be included in the Prospectus has been omitted therefrom. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Issuer Free Writing Prospectus</I>.&nbsp;The Company (including its agents and representatives, other than the
Underwriters in their capacity as such) has not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any &#147;written communication&#148; (as defined in Rule 405 under the
Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Securities (each such communication by the Company or its agents and representatives (other than a communication referred to in clauses (i)&nbsp;(ii) and (iii)
below) an &#147;Issuer Free Writing Prospectus&#148;) other than (i)&nbsp;any document not constituting a prospectus pursuant to Section&nbsp;2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act, (ii)&nbsp;the Preliminary
Prospectus, (iii)&nbsp;the Prospectus, (iv)&nbsp;the documents listed on Annex A hereto as constituting the Time of Sale Information, including a term sheet substantially in the form of Annex B hereto, and (v)&nbsp;any electronic road show or other
written communications, in each case approved in writing in advance by the Representatives.&nbsp;Each such Issuer Free Writing Prospectus, including the investor presentation listed on <U>Annex C</U> hereto (the &#147;Investor Presentation&#148;),
complied in all material respects with the Securities Act, has been or will be (within the time period specified in Rule 433) filed in accordance with the Securities Act (to the extent required thereby) and the Time of Sale Information, when taken
together with each such Issuer Free Writing Prospectus, including the Investor Presentation, did not, and at the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation and warranty with respect to any statements or omissions made in each such Issuer Free Writing
Prospectus, including the Investor Presentation, in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in any Issuer Free
Writing Prospectus, including the Investor Presentation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Registration Statement and Prospectus</I>.&nbsp;The
Registration Statement is an &#147;automatic shelf registration statement&#148; as defined under Rule 405 of the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof; and no notice of objection
of the Commission to the use of such registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company.&nbsp;No order suspending the effectiveness of the Registration
Statement has been issued by the Commission and no proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act against the Company or related to the offering has been initiated or threatened by the Commission; as of the
applicable effective date of the Registration Statement and any amendment thereto, the Registration Statement complied and will comply in all material respects with the Securities Act and the Trust Indenture Act of 1939, as amended, and the rules
and regulations of the Commission thereunder (collectively, the &#147;Trust Indenture Act&#148;), and did not and will not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading; and as of the
date of the Prospectus and any amendment or supplement thereto and as of the Closing Date, the Prospectus will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation and warranty with respect to (i)&nbsp;that part of the Registration Statement that
constitutes the Statement of Eligibility and Qualification (Form <FONT STYLE="white-space:nowrap">T-1)</FONT> of the Trustee under the Trust Indenture Act or (ii)&nbsp;any statements or omissions made in reliance upon and in conformity with
information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in the Registration Statement and the Prospectus and any amendment or supplement thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Incorporated Documents</I>.&nbsp;The documents incorporated by reference in the Registration Statement, the Prospectus
and the Time of Sale Information, when they were filed with the Commission conformed in all material respects to the requirements of the Exchange Act and none of such documents contained any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; and any further documents so filed and incorporated by reference in the
Registration Statement, the Prospectus or the Time of Sale Information, when such documents are filed with the Commission will conform in all material respects to the requirements of the Exchange Act and will not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Financial Statements</I>.&nbsp;The financial statements and the related notes thereto included or incorporated by
reference in the Registration Statement, the Time of Sale Information and the Prospectus comply in all material respects with the applicable requirements of the Securities Act and the Exchange Act, as applicable, and present fairly the financial
position of the Company and its subsidiaries as of the dates indicated and the results of their operations and the changes in their cash flows for the periods specified; such financial statements have been prepared in conformity with generally
accepted accounting principles applied on a consistent basis throughout the periods covered thereby, and the supporting schedules included or incorporated by reference in the Registration Statement present fairly the information required to be
stated therein; and the other financial information included or incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus has been derived from the accounting records of the Company and its subsidiaries
and presents fairly the information shown thereby. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>No Material Adverse Change</I>.&nbsp;Since the date of the most
recent financial statements of the Company included or incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus, (i)&nbsp;there has not been any change in the capital stock or consolidated long-term
debt of the Company or any of its subsidiaries, or any dividend or distribution of any kind declared, set aside for payment, paid or made by the Company on any class of capital stock, or any material adverse change, or any development involving a
prospective material adverse change, in or affecting the business, properties, management, financial position, results of operations or prospects of the Company and its subsidiaries taken as a whole (other than (x)&nbsp;the repurchase of shares of
Common Stock pursuant to the Company&#146;s stock repurchase program disclosed in the Registration Statement, (y)&nbsp;the issuance of shares of common stock pursuant to the Company&#146;s equity compensation plans and (z)&nbsp;issuances of capital
stock by wholly-owned subsidiaries of the Company to the Company or other wholly-owned subsidiaries of the Company or repurchases of capital stock of wholly-owned subsidiaries of the Company by the Company or other wholly-owned subsidiaries of the
Company); (ii) neither the Company nor any of its subsidiaries has entered into any transaction or agreement that is material to the Company and its subsidiaries taken as a whole or incurred any liability or obligation, direct or contingent, that is
material to the Company and its subsidiaries taken as a whole; and (iii)&nbsp;neither the Company nor any of its subsidiaries has sustained any material loss or interference with its business from fire, explosion, flood or other calamity, whether or
not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court or arbitrator or governmental or regulatory authority; except in each case as otherwise disclosed in the Registration Statement, the Time
of Sale Information and the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Organization and Good Standing</I>.&nbsp;The Company and each of its
&#147;significant subsidiaries&#148;, as such term is defined in Rule <FONT STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Exchange Act (the &#147;Significant Subsidiaries&#148;), have been
duly organized and are validly existing and in good standing (or the foreign equivalent thereof) under the laws of their respective jurisdictions of organization, are duly qualified to do business and are in good standing in each jurisdiction in
which their respective ownership or lease of property or the conduct of their respective businesses requires such qualification, and have all power and authority necessary to own or hold their respective properties and to conduct the businesses in
which they are engaged, except where the failure to be so qualified, in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect on the business, properties, management, financial
position or results of operations of the Company and its subsidiaries taken as a whole or on the performance by the Company of its obligations under the Securities (a &#147;Material Adverse Effect&#148;).&nbsp;The subsidiaries listed in Exhibit 21.1
to the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for its fiscal year ended October&nbsp;31, 2020 are the only Significant Subsidiaries of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Capitalization</I>.&nbsp;All the outstanding shares of capital stock or other equity interests of each subsidiary of the
Company have been duly and validly authorized and issued, are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> (except as otherwise described in the Registration Statement, the Time of Sale Information and the Prospectus and, in
the case of any foreign subsidiary, for directors&#146; qualifying shares) and are owned directly or indirectly by the Company (except as disclosed in the Registration Statement, the Time of Sale Information and the Prospectus), free and clear of
any lien, charge, encumbrance, security interest, restriction on voting or transfer or any other claim of any third party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>Due Authorization</I>.&nbsp;The Company has full right, power and authority to execute and deliver this Agreement, the
Securities and the Indenture (collectively, the &#147;Transaction Documents&#148;) and to perform its obligations hereunder and thereunder; and all action required to be taken by the Company for the due and proper authorization, execution and
delivery by the Company of each of the Transaction Documents and the consummation of the transactions contemplated thereby by the Company has been duly and validly taken. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>The Indenture</I>.&nbsp;The Base Indenture has been duly authorized by the Company and, as of the Closing Date, the Base
Indenture (i)&nbsp;will have been duly executed and delivered in accordance with its terms by the Company, (ii)&nbsp;will constitute a valid and legally binding agreement of the Company enforceable against the Company in accordance with its terms,
except as enforceability may be limited by applicable bankruptcy, insolvency or similar laws affecting the enforcement of creditors&#146; rights generally or by equitable principles relating to enforceability (collectively, the &#147;Enforceability
Exceptions&#148;) and (iii)&nbsp;will have been duly qualified under the Trust Indenture Act. The First Supplemental Indenture has been duly authorized by the Company and, when duly executed and delivered in accordance with its terms by each of the
parties thereto, will have been duly qualified under the Trust Indenture Act and will constitute a valid and legally binding agreement of the Company enforceable against the Company in accordance with its terms, subject to the Enforceability
Exceptions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>The Securities</I>.&nbsp;The Securities have been duly authorized by the Company and, when duly
executed, authenticated, issued and delivered as provided in the Indenture and paid for as provided herein, will be duly and validly issued and outstanding and will constitute valid and legally binding obligations of the Company enforceable against
the Company in accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Underwriting Agreement</I>.&nbsp;This Agreement has been duly authorized, executed and delivered by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <I>Descriptions of the Transaction Documents</I>.&nbsp;Each Transaction Document conforms in all material respects to the
description thereof contained in the Registration Statement, the Time of Sale Information and the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <I>No Violation or Default</I>.&nbsp;Neither the Company nor any of its
subsidiaries is (i)&nbsp;in violation of its charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> or similar organizational documents; (ii)&nbsp;in default, and no event has occurred that, with notice or lapse of time or both, would constitute
such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party
or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject; or (iii)&nbsp;in violation of any law or statute or any judgment, order, rule&nbsp;or
regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (ii)&nbsp;and (iii)&nbsp;above, for any such default or violation that would not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) <I>No Conflicts</I>.&nbsp;The execution, delivery and performance by the Company of
each of the Transaction Documents, the issuance and sale of the Securities and compliance by the Company with the terms thereof and the consummation of the transactions contemplated by the Transaction Documents will not (i)&nbsp;conflict with or
result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any of its subsidiaries
pursuant to any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the
property or assets of the Company or any of its subsidiaries is subject, (ii)&nbsp;result in any violation of the provisions of the charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> or similar organizational documents of the Company or any
of its subsidiaries or (iii)&nbsp;result in the violation of any law or statute or any judgment, order, rule&nbsp;or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (i)&nbsp;and
(iii)&nbsp;above, for any such conflict, breach, violation or default that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) <I>No Consents Required</I>.&nbsp;No consent, approval, authorization, order, registration or qualification of or with any
court or arbitrator or governmental or regulatory authority is required for the execution, delivery and performance by the Company of each of the Transaction Documents, the issuance and sale of the Securities and compliance by the Company with the
terms thereof and the consummation of the transactions contemplated by the Transaction Documents, except for the registration of the Securities under the Securities Act, the qualification of the Indenture under the Trust Indenture Act and such
consents, approvals, authorizations, orders and registrations or qualifications as may be required under applicable state securities laws in connection with the purchase and distribution of the Securities by the Underwriters. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) <I>Legal Proceedings</I>.&nbsp;Except as described in the Registration Statement, the Time of Sale Information and the
Prospectus, there are no legal, governmental or regulatory investigations, actions, suits or proceedings pending to which the Company or any of its subsidiaries is a party or to which any property of the Company or any of its subsidiaries is the
subject that, individually or in the aggregate, could reasonably be expected to have a Material Adverse Effect; no such investigations, actions, suits or proceedings are threatened or, to the knowledge of the Company, contemplated by any
governmental or regulatory authority or threatened by others; and (i)&nbsp;there are no current or pending legal, governmental or regulatory actions, suits or proceedings that are required under the Securities Act to be described in the Registration
Statement or the Prospectus that are not so described in the Registration Statement, the Time of Sale Information and the Prospectus and (ii)&nbsp;there are no statutes, regulations or contracts or other documents that are required under the
Securities Act to be filed as exhibits to the Registration Statement or described in the Registration Statement and the Prospectus that are not so filed as exhibits to the Registration Statement or described in the Registration Statement, the Time
of Sale Information and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) <I>Independent Accountants</I>.&nbsp;PricewaterhouseCoopers LLP, who have
certified certain financial statements of the Company and its subsidiaries, is an independent registered public accounting firm with respect to the Company and its subsidiaries within the applicable rules&nbsp;and regulations adopted by the
Commission and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act and the Exchange Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) <I>Title to Real and Personal Property</I>.&nbsp;The Company and its
subsidiaries have good and marketable title in fee simple to, or have valid rights to lease or otherwise use, all items of real and personal property that are material to the respective businesses of the Company and its subsidiaries, in each case
free and clear of all liens, encumbrances, claims and defects and imperfections of title except those that (i)&nbsp;do not materially interfere with the use made and proposed to be made of such property by the Company and its subsidiaries or
(ii)&nbsp;could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u)
<I>Title to Intellectual Property</I>.&nbsp;To the knowledge of the Company, (i)&nbsp;the Company and its subsidiaries own or possess adequate rights to use all material patents, patent applications, trademarks, service marks, trade names, trademark
registrations, service mark registrations, copyrights, licenses, domain names (in each case including all registrations and applications to register same) and <FONT STYLE="white-space:nowrap">know-how</FONT> (including trade secrets and other
unpatented and/or unpatentable proprietary or confidential information, systems or procedures) (&#147;Intellectual Property&#148;) necessary for the conduct of their respective businesses; (ii)&nbsp;there is no infringement of any such Intellectual
Property by any third parties; (iii)&nbsp;there is no pending or threatened action, suit, proceeding or claim by any third party challenging the Company&#146;s or its subsidiaries&#146; rights in or to any such Intellectual Property; (iv)&nbsp;there
is no pending or threatened action, suit, proceeding or claim by any third party challenging the validity, scope or enforceability of any such Intellectual Property; (v)&nbsp;the conduct of Company&#146;s and its subsidiaries&#146; respective
businesses will not conflict in any material respect with any such rights of others; and (vi)&nbsp;the Company and its subsidiaries have not received any notice of any claim of infringement or conflict with any such rights of others, except, in each
case, where the same would not reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) <I>No Undisclosed
Relationships</I>.&nbsp;No relationship, direct or indirect, exists between or among the Company or any of its subsidiaries, on the one hand, and the directors, officers, stockholders, customers or suppliers of the Company or any of its
subsidiaries, on the other, that is required by the Securities Act to be described in the Registration Statement and the Prospectus and that is not so described in such documents and in the Time of Sale Information. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) <I>Investment Company Act</I>.&nbsp;The Company is not and, after giving effect to the offering and sale of the Securities
and the application of the proceeds thereof as described in the Registration Statement, the Time of Sale Information and the Prospectus, will not be required to register as an &#147;investment company&#148; or an entity &#147;controlled&#148; by an
&#147;investment company&#148; within the meaning of the Investment Company Act of 1940, as amended, and the rules&nbsp;and regulations of the Commission thereunder (collectively, &#147;Investment Company Act&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) <I>Taxes</I>.&nbsp;Except as otherwise disclosed in the Registration Statement, the Time of Sale Information and the
Prospectus, (i)&nbsp;the Company and its subsidiaries have paid all federal, state, local and foreign taxes required to be paid and filed all tax returns required to be filed, in each case, through the date hereof, except for such failures to pay or
file as would not individually or in the aggregate have a Material Adverse Effect, and (ii)&nbsp;there is no tax deficiency that has been, or could reasonably be expected to be, asserted against the Company or any of its subsidiaries or any of their
respective properties or assets, in each case that would, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y) <I>Licenses and Permits</I>.&nbsp;The Company and its subsidiaries possess all licenses, certificates, permits and other
authorizations issued by, and have made all declarations and filings with, the appropriate federal, state, local or foreign governmental or regulatory authorities that are necessary for the ownership or lease of their respective properties or the
conduct of their respective businesses as described in the Registration Statement, the Time of Sale Information and the Prospectus, except where the failure to possess or make the same would not, individually or in the aggregate, have a Material
Adverse Effect; and except as described in the Registration Statement, the Time of Sale Information and the Prospectus, neither the Company nor any of its subsidiaries has received notice of any revocation or modification of any such license,
certificate, permit or authorization or has any reason to believe that any such license, certificate, permit or authorization will not be renewed in the ordinary course. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z) <I>No Labor Disputes</I>.&nbsp;No labor disturbance by or dispute with
employees of the Company or any of its subsidiaries exists or, to the knowledge of the Company, is contemplated or threatened and the Company is not aware of any existing or imminent labor disturbance by, or dispute with, the employees of any of its
or its subsidiaries&#146; principal suppliers, contractors or customers, except as would not have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa) <I>Compliance With Environmental Laws</I>.&nbsp;Except as otherwise disclosed in the Registration Statement, the Time of
Sale Information and the Prospectus, (i)&nbsp;the Company and its subsidiaries (x)&nbsp;are, and at all prior times were, in compliance with any and all applicable federal, state, local and foreign laws, rules, regulations, requirements, decisions
and orders relating to the protection of human health or safety, the environment, natural resources, hazardous or toxic substances or wastes, pollutants or contaminants (collectively, &#147;Environmental Laws&#148;); (y)&nbsp;have received and are
in compliance with all permits, licenses, certificates or other authorizations or approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (z)&nbsp;have not received notice of any actual or potential
liability under or relating to any Environmental Laws, including for the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, and have no knowledge of any event or condition
that would reasonably be expected to result in any such notice, and (ii)&nbsp;there are no costs or liabilities associated with Environmental Laws of or relating to the Company or its subsidiaries, except in the case of each of (i)&nbsp;and
(ii)&nbsp;above, for any such failure to comply, or failure to receive required permits, licenses or approvals, or cost or liability, as would not, individually or in the aggregate, have a Material Adverse Effect; and (iii)&nbsp;except as described
in each of the Time of Sale Information and the Prospectus, (x)&nbsp;there are no proceedings that are pending, or that are known to be threatened, against the Company or any of its subsidiaries under any Environmental Laws in which a governmental
entity is also a party and&nbsp;(y)&nbsp;the Company and its subsidiaries are not aware of any issues regarding compliance with Environmental Laws, or liabilities or other obligations under Environmental Laws or concerning hazardous or toxic
substances or wastes, pollutants or contaminants, except in the case of each of (x)&nbsp;and (y) above, as would not, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb) <I>Compliance With ERISA</I>.&nbsp;(i) Each &#147;employee benefit plan,&#148; within the meaning of Section&nbsp;3(3) of
the Employee Retirement Income Security Act of 1974, as amended (&#147;ERISA&#148;), which the Company or its subsidiaries or, with respect to any such plan that is subject to Section&nbsp;412 of the Internal Revenue Code of 1986, as amended (the
&#147;Code&#148;), Section&nbsp;302 of ERISA or Title IV of ERISA, any member of its &#147;Controlled Group&#148; (defined as any entity, trade or business (whether or not incorporated) which is a member of a controlled group of corporations within
the meaning of Section&nbsp;414 of the Code or Section&nbsp;4001(a)(14) of ERISA) sponsors, maintains, contributes to or with respect to which it has or would have any liability or obligation, contingent or otherwise, other than a
&#147;multiemployer plan&#148;, within the meaning of Section&nbsp;4001(a)(3) of ERISA (each, a &#147;Plan&#148;), is in compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not
limited to ERISA and the Code; (ii)&nbsp;no prohibited transaction, within the meaning of Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code involving the responsible Plan fiduciary, has occurred with respect to any Plan, excluding
transactions effected pursuant to a statutory or administrative exemption; (iii)&nbsp;no Plan that is subject to the funding rules of Section&nbsp;412 of the Code or Section&nbsp;302 of ERISA, has failed to satisfy the minimum funding standards (as
defined in Section&nbsp;412 of the Code or Section&nbsp;302 of ERISA), whether or not waived; (iv)&nbsp;the fair market value of the assets of each Plan exceeds the present value of all benefits accrued under such Plan (determined as of the date of
the most recent actuarial valuation report for such Plan based on those assumptions used to fund such Plan as used in such actuarial valuation); (v) no &#147;reportable event&#148; (within the meaning of Section&nbsp;4043(c) of ERISA) as to which
the <FONT STYLE="white-space:nowrap">30-day</FONT> notice period has not been waived by regulation or otherwise has occurred or is reasonably expected to occur with respect to any Plan; (vi)&nbsp;there exists no event or condition which would
reasonably be expected to result in the institution of proceedings to terminate any Plan under Section&nbsp;4042 of ERISA; and (vii)&nbsp;neither the Company or any member of its Controlled Group has incurred, or reasonably expects to incur, any
liability (A)&nbsp;under Title IV of ERISA (other than premiums to the Pension Benefit Guaranty Corporation under Section&nbsp;4007 of ERISA, in the ordinary course and without default) in respect of a Plan, or (B)&nbsp;with respect to the complete
withdrawal or partial withdrawal (within the meanings of Sections 4203 and 4205 of ERISA) from any multiemployer plan (within the meaning of Section&nbsp;4001(a)(3) of ERISA), except, in the case of each of the preceding clauses (i)&nbsp;through
(vii), where the same would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc) <I>Disclosure Controls</I>.&nbsp;Except as disclosed in the
Registration Statement, the Time of Sale Information and the Prospectus, the Company and its subsidiaries maintain an effective system of &#147;disclosure controls and procedures&#148; (as defined in
<FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15(e)&nbsp;of</FONT> the Exchange Act) that is designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded,
processed, summarized and reported within the time periods specified in the Commission&#146;s rules&nbsp;and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company&#146;s
management as appropriate to allow timely decisions regarding required disclosure.&nbsp;The Company and its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and procedures as required by <FONT
STYLE="white-space:nowrap">Rule&nbsp;13a-15</FONT> of the Exchange Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd) <I>Accounting Controls</I>.&nbsp;Except as
disclosed in the Registration Statement, the Time of Sale Information and the Prospectus, the Company and its subsidiaries maintain systems of &#147;internal control over financial reporting&#148; (as defined in
<FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15(f)&nbsp;of</FONT> the Exchange Act) that comply with the requirements of the Exchange Act and have been designed by, or under the supervision of, their respective principal executive and principal
financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles, including, but not limited to internal accounting controls sufficient to provide reasonable assurance that (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations;
(ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain asset accountability; (iii)&nbsp;access to assets is permitted only in
accordance with management&#146;s general or specific authorization; and (iv)&nbsp;the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any
differences.&nbsp;Except as disclosed in the Registration Statement, the Time of Sale Information and the Prospectus, there are no material weaknesses in the Company&#146;s internal controls. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee) <I>Insurance</I>.&nbsp;The Company and its subsidiaries have insurance (including self insurance) covering their
respective properties, operations, personnel and businesses, including business interruption insurance, which insurance (including self insurance) is in amounts and insures against such losses and risks as are prudent and customary for companies
engaged in similar businesses in similar industries and adequate to protect the Company and its subsidiaries and their respective businesses; and neither the Company nor any of its subsidiaries has (i)&nbsp;received notice from any insurer or agent
of such insurer that material capital improvements or other material expenditures are required or necessary to be made in order to continue such insurance or (ii)&nbsp;any reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage at reasonable cost from similar insurers as may be necessary to continue its business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ff) <I>No Unlawful Payments</I>.&nbsp;Neither the Company nor any of its subsidiaries nor, to the knowledge of the Company,
any director, officer, agent, employee or other person associated with or acting on behalf of the Company or any of its subsidiaries has (i)&nbsp;used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense
relating to political activity; or (ii)&nbsp;made or took any unlawful action in furtherance of any direct or indirect unlawful payment to any foreign or domestic government official or employee (including any officer or employee of a government or
government-owned or controlled entity or of a public international organization, or any person acting in an official capacity or candidate for political office) from corporate or other funds.&nbsp;The Company and its subsidiaries have conducted and
currently conduct business in compliance with applicable anti-corruption laws, including the U.S. Foreign Corrupt Practices Act of 1977 or the U.K. Bribery Act 2010, each as may be amended, or similar law of any other relevant jurisdiction, or the
rules or regulations thereunder, and have instituted and maintain policies and procedures designed to ensure compliance with such laws. No part of the proceeds of the offering will be used by the Company or any of its subsidiaries, directly or
indirectly, in violation of the U.S. Foreign Corrupt Practices Act of 1977 or the U.K. Bribery Act 2010, each as may be amended, or similar applicable law of any other relevant jurisdiction, or the rules or regulations thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(gg) <I>Compliance with Money Laundering Laws</I>.&nbsp;The operations of
the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money
laundering statutes of all jurisdictions, the rules&nbsp;and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#147;Money Laundering
Laws&#148;) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the
knowledge of the Company, threatened. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hh) <I>Compliance with OFAC</I>.&nbsp;(i) None of the Company, any of its
subsidiaries or, to the knowledge of the Company, any director, officer, agent, employee or Affiliate of the Company or any of its subsidiaries is, or is controlled or majority owned by or acting on behalf of, an individual or entity that is,
currently subject to any sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury (&#147;OFAC&#148;), the United Nations Security Council, the European Union, the United Kingdom (including sanctions
enforced by Her Majesty&#146;s Treasury) or other relevant sanctions authority (collectively, &#147;Sanctions&#148;) and (ii)&nbsp;(A) neither the Company nor any of its subsidiaries is located in a country or territory that is, or whose government
is, the subject of Sanctions (including, without limitation, Crimea, Cuba, Iran, North Korea, Venezuela and Syria) that broadly prohibit dealings with that country or territory, in each case in violation of Sanctions and (B)&nbsp;none of the
Company, any of its subsidiaries or, to the knowledge of the Company, any director, officer, employee or Affiliate of the Company or any of its subsidiaries is organized or resident in a country or territory that is, or whose government is, the
subject of Sanctions (including, without limitation, Crimea, Cuba, Iran, North Korea, Venezuela and Syria) that broadly prohibit dealings with that country or territory, in each case in violation of Sanctions; and the Company will not directly or
indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of
any person currently subject to any Sanctions. For the past 3 years, the Company and its subsidiaries have not knowingly engaged in and are not now knowingly engaged in any dealings or transactions with any person, or in any country or territory,
that is at the time of the dealing or transaction is or was the subject of Sanctions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <I>Solvency</I>.&nbsp;On and
immediately after the Closing Date, the Company (after giving effect to the issuance of the Securities and the other transactions related thereto as described in the Registration Statement, the Time of Sale Information and the Prospectus) will be
Solvent.&nbsp;As used in this paragraph, the term &#147;Solvent&#148; means, with respect to a particular date, that on such date (i)&nbsp;the present fair market value (or present fair saleable value) of the assets of the Company is not less than
the total amount required to pay the liabilities of the Company on its total existing debts and liabilities (including contingent liabilities) as they become absolute and matured; (ii)&nbsp;the Company is able to realize upon its assets and pay its
debts and other liabilities, contingent obligations and commitments as they mature and become due in the normal course of business; (iii)&nbsp;assuming consummation of the issuance of the Securities as contemplated by this Agreement, the
Registration Statement, the Time of Sale Information and the Prospectus, the Company is not incurring debts or liabilities beyond its ability to pay as such debts and liabilities mature; and (iv)&nbsp;the Company is not engaged in any business or
transaction, and does not propose to engage in any business or transaction, for which its property would constitute unreasonably small capital after giving due consideration to the prevailing practice in the industry in which the Company is engaged.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jj) <I>No Restrictions on Subsidiaries</I>.&nbsp;No material subsidiary of the Company is currently prohibited, directly
or indirectly, under any agreement or other instrument to which it is a party or is subject, from: (i)&nbsp;paying any dividends to the Company, from making any other distribution on such subsidiary&#146;s capital stock; (ii)&nbsp;repaying to the
Company any loans or advances to such subsidiary from the Company; or (iii)&nbsp;transferring any of such subsidiary&#146;s properties or assets to the Company or any other subsidiary of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kk) <I>No Broker&#146;s Fees</I>.&nbsp;Neither the Company nor any of its subsidiaries is a party to any contract, agreement
or understanding with any person (other than this Agreement) that would give rise to a valid claim against the Company or any of its subsidiaries or any Underwriter for a brokerage commission, finder&#146;s fee or like payment in connection with the
offering and sale of the Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ll) <I>No Registration Rights</I>.&nbsp;No person has the right to require
the Company or any of its subsidiaries to register any securities for sale under the Securities Act by reason of the filing of the Registration Statement with the Commission or the issuance and sale of the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(mm) <I>No Stabilization</I>.&nbsp;The Company has not taken, directly or indirectly, any action designed to or that could
reasonably be expected to cause or result in any stabilization or manipulation of the price of the Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(nn)
<I>Margin Rules</I>.&nbsp;Neither the issuance, sale and delivery of the Securities nor the application of the proceeds thereof by the Company as described in the Registration Statement, the Time of Sale Information and the Prospectus will violate
Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(oo) <I>Forward-Looking Statements</I>.&nbsp;No forward-looking statement (within the meaning of Section&nbsp;27A of the
Securities Act and Section&nbsp;21E of the Exchange Act) contained in the Registration Statement, the Time of Sale Information and the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(pp) <I>Statistical and Market Data</I>.&nbsp;Nothing has come to the attention of the Company that has caused the Company
to believe that the statistical and market-related data included in the Registration Statement, the Time of Sale Information and the Prospectus is not based on or derived from sources that are reliable and accurate in all material respects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(qq) <I>Sarbanes-Oxley Act</I>.&nbsp;There is and has been no failure on the part of the Company or any of the Company&#146;s
directors or officers, in their capacities as such, to comply with any provision of the Sarbanes-Oxley Act of 2002 and the rules&nbsp;and regulations promulgated in connection therewith (the &#147;Sarbanes-Oxley Act&#148;), including
Section&nbsp;402 related to loans and Sections 302 and 906 related to certifications. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(rr) <I>Status under the Securities
Act</I>.&nbsp;The Company is not an ineligible issuer and is a well-known seasoned issuer, in each case as defined under the Securities Act, in each case at the times specified in the Securities Act in connection with the offering of the
Securities.&nbsp;At the time of the filing of the Prospectus Supplement, the Company has paid the registration fee for this offering pursuant to Rule&nbsp;457 under the Securities Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ss) <I>XBRL</I>. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the
Registration Statement fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#146;s rules&nbsp;and guidelines applicable thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(tt) <I>Cybersecurity</I>.&nbsp;The Company and its subsidiaries&#146; information technology assets and equipment, computers,
systems, networks, hardware, software, websites, applications, and databases (collectively, &#147;IT Systems&#148;) are adequate for, and operate and perform in all material respects as required in connection with the operation of the business of
the Company and its subsidiaries as currently conducted, free and clear of all material bugs, errors, defects, trojan horses, time bombs, malware and other corruptants. The Company and its subsidiaries have implemented and maintained commercially
reasonable controls, policies, procedures, and safeguards to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data (including all personal, personally
identifiable, sensitive, confidential or regulated data (&#147;Personal Data&#148;)) used in connection with their businesses, and there have been no breaches, violations, outages or unauthorized uses of or accesses to same, except for those that
have been remedied without material cost or liability or the duty to notify any other person, nor any incidents under internal review or investigations relating to the same. The Company and its subsidiaries are presently in material compliance with
all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and
Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Further Agreements of the Company</U>.&nbsp;The Company covenants and
agrees with each Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Required Filings</I>.&nbsp;The Company will file the final Prospectus with the
Commission within the time periods specified by Rule&nbsp;424(b)&nbsp;and Rule&nbsp;430A, 430B or 430C under the Securities Act, will file any Issuer Free Writing Prospectus (including one or more term sheets in the form of Annex B hereto) to the
extent required by Rule&nbsp;433 under the Securities Act; and will file promptly all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or
15(d)&nbsp;of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus is required in connection with the offering or sale of the Securities; and the Company will furnish copies of the Prospectus and
each Issuer Free Writing Prospectus (to the extent not previously delivered) to the Underwriters in New York City prior to 10:00&nbsp;A.M., New York City time, on the business day next succeeding the date of this Agreement in such quantities as the
Representatives may reasonably request. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Delivery of Copies</I>.&nbsp;The Company will deliver, without charge,
(i)&nbsp;to each Representative, two signed copies of the Registration Statement as originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith and documents incorporated by reference therein; and
(ii)&nbsp;to each Underwriter (A)&nbsp;a conformed copy of the Registration Statement as originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith and (B)&nbsp;during the Prospectus Delivery Period
(as defined below), as many copies of the Prospectus (including all amendments and supplements thereto and documents incorporated by reference therein) and each Issuer Free Writing Prospectus as each Representative may reasonably request.&nbsp;As
used herein, the term &#147;Prospectus Delivery Period&#148; means such period of time after the first date of the public offering of the Securities as in the opinion of counsel for the Underwriters a prospectus relating to the Securities is
required by law to be delivered (or required to be delivered but for Rule&nbsp;172 under the Securities Act) in connection with sales of the Securities by any Underwriter or dealer. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Amendments or Supplements; Issuer Free Writing Prospectuses</I>.&nbsp;Before making, preparing, using, authorizing,
approving, referring to or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement or the Prospectus, the Company will furnish to the Representatives and counsel for the Underwriters a
copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for review and will not make, prepare, use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any such proposed amendment or supplement
to which any Representative reasonably objects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Notice to the Representatives</I>.&nbsp;The Company will advise the
Representatives promptly, and confirm such advice in writing, (i)&nbsp;when the Registration Statement has become effective; (ii)&nbsp;when any amendment to the Registration Statement has been filed or becomes effective; (iii)&nbsp;when any
supplement to the Prospectus or any amendment to the Prospectus or any Issuer Free Writing Prospectus has been filed; (iv)&nbsp;of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the
Prospectus or the receipt of any comments from the Commission relating to the Registration Statement or any other request by the Commission for any additional information; (v)&nbsp;of the issuance by the Commission of any order suspending the
effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary Prospectus or the Prospectus or the initiation or threatening of any proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act;
(vi)&nbsp;of the occurrence of any event within the Prospectus Delivery Period as a result of which the Prospectus, the Time of Sale Information or any Issuer Free Writing Prospectus (including the Investor Presentation) as then amended or
supplemented would include any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus,
the Time of Sale Information, any such Issuer Free Writing Prospectus (including the Investor Presentation) is delivered to a purchaser, not misleading; (vii)&nbsp;of the receipt by the Company of any notice of objection of the Commission to the use
of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the Registration Statement or any post-effective amendment thereto pursuant to Rule&nbsp;401(g)(2)&nbsp;under the Securities Act; and (viii)&nbsp;of the receipt by the Company of any notice with
respect to any suspension of the qualification of the Securities for offer and sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and the Company will use its reasonable best efforts to prevent the issuance
of any such order suspending the effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus or the Prospectus or suspending any such qualification of the Securities and, if any such order is issued,
will obtain as soon as possible the withdrawal thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Time of Sale Information</I>.&nbsp;If at any time prior to
the Closing Date (i)&nbsp;any event shall occur or condition shall exist as a result of which the Time of Sale Information as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements therein, in the light of the circumstances, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Time of Sale Information to comply with law, the Company will immediately notify the
Underwriters thereof and forthwith prepare and, subject to paragraph (c)&nbsp;above, file with the Commission (to the extent required) and furnish to the Underwriters and to such dealers as the Representatives may designate, such amendments or
supplements to the Time of Sale Information as may be necessary so that the statements in the Time of Sale Information as so amended or supplemented will not, in the light of the circumstances, be misleading or so that the Time of Sale Information
will comply with law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Ongoing Compliance</I>.&nbsp;If during the Prospectus Delivery Period (i)&nbsp;any event
shall occur or condition shall exist as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to
make the statements therein, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Prospectus to comply with law, the Company will
immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c)&nbsp;of this Section&nbsp;4, file with the Commission and furnish to the Underwriters and to such dealers as the Representatives may designate, such
amendments or supplements to the Prospectus as may be necessary so that the statements in the Prospectus as so amended or supplemented will not, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, be
misleading or so that the Prospectus will comply with law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Blue Sky Compliance</I>.&nbsp;The Company will qualify
the Securities for offer and sale under the securities or Blue Sky laws of such jurisdictions as the Representatives shall reasonably request and will continue such qualifications in effect so long as required for distribution of the Securities;
<U>provided</U> that the Company shall not be required to (i)&nbsp;qualify as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii)&nbsp;file any
general consent to service of process in any such jurisdiction or (iii)&nbsp;subject itself to taxation in any such jurisdiction if it is not otherwise so subject. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Earning Statement</I>.&nbsp;The Company will make generally available to its security holders and the Representatives as
soon as practicable an earning statement that satisfies the provisions of Section&nbsp;11(a)&nbsp;of the Securities Act and Rule&nbsp;158 of the Commission promulgated thereunder covering a period of at least twelve months beginning with the first
fiscal quarter of the Company occurring after the &#147;effective date&#148; (as defined in Rule&nbsp;158) of the Registration Statement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Clear Market</I>.&nbsp;During the period from the date hereof through and including the business day following the
Closing Date, the Company will not, without the prior written consent of the Representatives, offer, sell, contract to sell or otherwise dispose of any debt securities issued or guaranteed by the Company and having a tenor of more than one year.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>Use of Proceeds</I>.&nbsp;The Company will apply the net proceeds from the sale of the Securities as described in
the Registration Statement, the Time of Sale Information and the Prospectus under the heading &#147;Use of Proceeds&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>No Stabilization</I>.&nbsp;The Company will not take, directly or
indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>Record Retention</I>.&nbsp;The Company will, pursuant to reasonable procedures developed in good faith, retain copies of
each Issuer Free Writing Prospectus that is not filed with the Commission in accordance with Rule&nbsp;433 under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.
<U>Certain Agreements of the Underwriters</U>.&nbsp;Each Underwriter hereby represents and agrees that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) It has not and
will not use, authorize use of, refer to, or participate in the planning for use of, any &#147;free writing prospectus&#148;, as defined in Rule&nbsp;405 under the Securities Act (which term includes use of any written information furnished to the
Commission by the Company and not incorporated by reference into the Registration Statement and any press release issued by the Company) other than (i)&nbsp;a free writing prospectus that, solely as a result of use by such underwriter, would not
trigger an obligation to file such free writing prospectus with the Commission pursuant to Rule&nbsp;433, (ii)&nbsp;any Issuer Free Writing Prospectus listed on Annex A or prepared pursuant to Section&nbsp;3(c)&nbsp;or Section&nbsp;4(c)&nbsp;above
(including any electronic road show), or (iii)&nbsp;any free writing prospectus prepared by such underwriter and approved by the Company in advance in writing.&nbsp;Notwithstanding the foregoing, the Underwriters may use customary Bloomberg
communications containing preliminary terms of the securities and the information set forth in the term sheet(s)&nbsp;filed pursuant to Section&nbsp;4(a)&nbsp;as well as any term sheet substantially in the form of Annex B hereto without the consent
of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) It is not subject to any pending proceeding under Section&nbsp;8A of the Securities Act with respect
to the offering (and will promptly notify the Company if any such proceeding against it is initiated during the Prospectus Delivery Period). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Conditions of Underwriters&#146; Obligations</U>.&nbsp;The obligation of each Underwriter to purchase Securities on the Closing Date as
provided herein is subject to the performance by the Company of its covenants and other obligations hereunder and to the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Registration Compliance; No Stop Order</I>.&nbsp;No order suspending the effectiveness of the Registration Statement
shall be in effect, and no proceeding for such purpose, pursuant to Rule&nbsp;401(g)(2)&nbsp;or pursuant to Section&nbsp;8A under the Securities Act shall be pending before or threatened by the Commission; the Prospectus and each Issuer Free Writing
Prospectus shall have been timely filed with the Commission under the Securities Act (in the case of an Issuer Free Writing Prospectus, to the extent required by Rule&nbsp;433 under the Securities Act) and in accordance with
Section&nbsp;4(a)&nbsp;hereof; and all requests by the Commission for additional information shall have been complied with to the reasonable satisfaction of the Representative. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Representations and Warranties</I>.&nbsp;The representations and warranties of the Company contained herein shall be
true and correct on the date hereof and on and as of the Closing Date; and the statements of the Company and its officers made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>No Downgrade</I>.&nbsp;Subsequent to the earlier of (A)&nbsp;the Time of Sale and (B)&nbsp;the execution and delivery of
this Agreement, (i)&nbsp;no downgrading shall have occurred in the rating accorded the Securities or any other debt securities or preferred stock of or guaranteed by the Company or any of its subsidiaries by any &#147;nationally recognized
statistical rating organization&#148;, as such term is defined under Section&nbsp;3(a)(62) under the Exchange Act and (ii)&nbsp;no such organization shall have publicly announced that it has under surveillance or review, or has changed its outlook
with respect to, its rating of the Securities or of any other debt securities or preferred stock of or guaranteed by the Company or any of its subsidiaries (other than an announcement with positive implications of a possible upgrading). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>No Material Adverse Change</I>.&nbsp;No event or condition of a type
described in Section&nbsp;3(g)&nbsp;hereof shall have occurred or shall exist, which event or condition is not described in each of the Time of Sale Information (excluding any amendment or supplement thereto) and the Prospectus (excluding any
amendment or supplement thereto) and the effect of which in the judgment of the Representatives makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by
this Agreement, the Time of Sale Information and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Officer&#146;s Certificate</I>.&nbsp;The
Representatives shall have received on and as of the Closing Date a certificate of an executive officer of the Company who has specific knowledge of the Company&#146;s financial matters and is satisfactory to the Representatives, in such
officer&#146;s capacity as an officer of the Company and not personally, (i)&nbsp;confirming that such officer has carefully reviewed the Registration Statement, the Time of Sale Information, as well as each electronic roadshow used in connection
with the offering of the securities, and the Prospectus and, to the knowledge of such officer, the representations set forth in Sections 3(b)&nbsp;or 3(d)&nbsp;hereof are true and correct, (ii)&nbsp;confirming that the other representations and
warranties of the Company in this Agreement are true and correct and that the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date and (iii)&nbsp;to
the effect set forth in paragraphs (a), (c)&nbsp;and (d)&nbsp;of this Section&nbsp;6. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Comfort Letters</I>.&nbsp;On
the date of this Agreement and on the Closing Date, PricewaterhouseCoopers LLP shall have furnished to the Representatives, at the request of the Company, letters, dated the respective date of delivery thereof and addressed to the Underwriters, in
form and substance reasonably satisfactory to the Representatives, containing statements and information of the type customarily included in accountants&#146; &#147;comfort letters&#148; to underwriters with respect to the financial statements and
certain financial information contained or incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus; <U>provided</U> that the letter delivered on the Closing Date shall use a <FONT
STYLE="white-space:nowrap">&#147;cut-off&#148;</FONT> date no more than three business days prior to the Closing Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)
[Intentionally omitted.] </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> Statement of Counsel for the
Company</I>.&nbsp;Goodwin Procter LLP, counsel for the Company, shall have furnished to the Representatives, at the request of the Company, their written opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> Statement, dated the Closing Date and
addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Opinion of
General Counsel for the Company</I>. Michael Tang, Senior Vice President, General Counsel and Secretary for the Company, shall have furnished to the Representatives, at the request of the Company, his written opinion, dated the Closing Date and
addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>Opinion and <FONT
STYLE="white-space:nowrap">10b-5</FONT> Statement of Counsel for the Underwriters</I>.&nbsp;The Representatives shall have received on and as of the Closing Date an opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> Statement of Simpson
Thacher&nbsp;&amp; Bartlett LLP, counsel for the Underwriters, with respect to such matters as the Representatives may reasonably request, and such counsel shall have received such documents and information as they may reasonably request to enable
them to pass upon such matters. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>No Legal Impediment to Issuance</I>.&nbsp;No action shall have been taken and no
statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Securities; and no injunction
or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date, prevent the issuance or sale of the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>Good Standing</I>.&nbsp;The Representatives shall have received on and as of the Closing Date satisfactory evidence of
the good standing of the Company in its jurisdiction of organization in writing or via customary bring-down letters of good standing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Additional Documents</I>.&nbsp;On or prior to the Closing Date, the
Company shall have furnished to the Representatives such further certificates and documents as the Representatives may reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All opinions, letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the
provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Indemnification
and Contribution</U>.&nbsp;(a)&nbsp;<I>Indemnification of the Underwriters</I>.&nbsp;The Company agrees to indemnify and hold harmless each Underwriter, its affiliates, directors and officers and each person, if any, who controls such Underwriter
within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, from and against any and all losses, claims, damages and liabilities (including, without limitation, reasonable legal fees and other reasonable
expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), joint or several, that arise out of, or are based upon, (i)&nbsp;any untrue statement or alleged untrue statement of
a material fact contained in the Registration Statement or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary in order to make the statements therein not misleading or (ii)&nbsp;any
untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), any Issuer Free Writing Prospectus (including the Investor Presentation) or any Time of Sale Information, or caused
by any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, in each case except insofar as such losses, claims,
damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to any Underwriter furnished to the Company in
writing by such Underwriter through the Representatives expressly for use therein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Indemnification of the Company</I>.&nbsp;Each
Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors, its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of
the Securities Act or Section&nbsp;20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a)&nbsp;above, but only with respect to any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue
statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to such Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for
use in the Registration Statement, the Prospectus (or any amendment or supplement thereto), any Issuer Free Writing Prospectus (including the Investor Presentation) or any Time of Sale Information, it being understood and agreed that the only such
information consists of the following:&nbsp;the concession and reallowance figures appearing in the third paragraph under the caption &#147;Underwriting&#148; in the Prospectus and the information contained in the sixth paragraph relating to
stabilization under the caption &#147;Underwriting&#148; in the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Notice and Procedures</I>.&nbsp;If any suit, action,
proceeding (including any governmental or regulatory investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to either paragraph (a)&nbsp;or (b)&nbsp;above, such
person (the &#147;Indemnified Person&#148;) shall promptly notify the person against whom such indemnification may be sought (the &#147;Indemnifying Person&#148;) in writing; <U>provided</U> that the failure to notify the Indemnifying Person shall
not relieve it from any liability that it may have under this Section&nbsp;7 except to the extent that it has been materially prejudiced by such failure; and <U>provided</U>, <U>further</U>, that the failure to notify the Indemnifying Person shall
not relieve it from any liability that it may have to an Indemnified Person otherwise than under this Section&nbsp;7.&nbsp;If any such proceeding shall be brought or asserted against an Indemnified Person and it shall have notified the Indemnifying
Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent the Indemnified Person
and any others entitled to indemnification pursuant to Section&nbsp;7 that the Indemnifying Party may designate in such proceeding and shall pay the fees and expenses of such proceeding and shall pay the fees and expenses of counsel related to such
proceeding, as incurred.&nbsp;In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i)&nbsp;the
Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii)&nbsp;the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii)&nbsp;the
Indemnified Person shall have reasonably concluded that there may be legal defenses available to it that are </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
different from or in addition to those available to the Indemnifying Person; or (iv)&nbsp;the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying
Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them.&nbsp;It is understood and agreed that the Indemnifying Person shall not, in
connection with any proceeding or related proceeding in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses
shall be reimbursed as they are incurred.&nbsp;Any such separate firm for any Underwriter, its affiliates, directors and officers and any control persons of such Underwriter shall be designated in writing by the Representatives and any such separate
firm for the Company, its directors, its officers who signed the Registration Statement and any control persons of the Company shall be designated in writing by the Company.&nbsp;The Indemnifying Person shall not be liable for any settlement of any
proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason
of such settlement or judgment.&nbsp;No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been
a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x)&nbsp;includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified
Person, from all liability on claims that are the subject matter of such proceeding and (y)&nbsp;does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Contribution</I>.&nbsp;If the indemnification provided for in paragraphs (a)&nbsp;and (b)&nbsp;above is unavailable to an Indemnified
Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid
or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other
from the offering of the Securities or (ii)&nbsp;if the allocation provided by clause (i)&nbsp;is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i)&nbsp;but also
the relative fault of the Company on the one hand and the Underwriters on the other in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable
considerations.&nbsp;The relative benefits received by the Company on the one hand and the Underwriters on the other shall be deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by the Company
from the sale of the Securities and the total underwriting discounts and commissions received by the Underwriters in connection therewith, in each case as set forth in the table on the cover of the Prospectus, bear to the aggregate offering price of
the Securities.&nbsp;The relative fault of the Company on the one hand and the Underwriters on the other shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information supplied by the Company or by the Underwriters and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Limitation on Liability</I>.&nbsp;The Company and the Underwriters agree that it would not be just and equitable if contribution
pursuant to this Section&nbsp;7 were determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable considerations referred to
in paragraph (d)&nbsp;above.&nbsp;The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d)&nbsp;above shall be deemed to include, subject to the limitations set forth
above, any legal or other expenses incurred by such Indemnified Person in connection with any such action or claim.&nbsp;Notwithstanding the provisions of this Section&nbsp;7, in no event shall an Underwriter be required to contribute any amount in
excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the offering of the Securities exceeds the amount of any damages that such Underwriter has otherwise been required to pay by
reason of such untrue or alleged untrue statement or omission or alleged omission.&nbsp;No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f)&nbsp;of the Securities Act) shall be entitled to contribution from any
person who was not guilty of such fraudulent misrepresentation.&nbsp;The Underwriters&#146; obligations to contribute pursuant to this Section&nbsp;7 are several in proportion to their respective purchase obligations hereunder and not joint. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I><FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Remedies</I>.&nbsp;The remedies provided for in this Section&nbsp;7 are not
exclusive and shall not limit any rights or remedies which may otherwise be available to any Indemnified Person at law or in equity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Effectiveness of Agreement</U>.&nbsp;This Agreement shall become effective upon the
execution and delivery hereof by the parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Termination</U>.&nbsp;This Agreement may be terminated in the absolute
discretion of the Representatives, by notice to the Company, if after the execution and delivery of this Agreement and prior to the Closing Date (i)&nbsp;trading generally shall have been suspended or materially limited on the New York Stock
Exchange, the Nasdaq Global Select Market or the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (ii)&nbsp;trading of any securities issued or guaranteed by the Company shall have been
suspended on any exchange or in any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (iii)&nbsp;a general moratorium on commercial banking activities shall have been declared by federal or New
York State authorities; or (iv)&nbsp;there shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the
Representatives, is material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale Information and the
Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Defaulting Underwriter</U>.&nbsp;(a)&nbsp;If, on the Closing Date, any Underwriter defaults on its obligation to
purchase the Securities that it has agreed to purchase hereunder, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters may in their discretion arrange for the purchase of such Securities by other persons satisfactory to the
Company on the terms contained in this Agreement.&nbsp;If, within 36 hours after any such default by any Underwriter, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters do not arrange for the purchase of such Securities, then
the Company shall be entitled to a further period of 36 hours within which to procure other persons satisfactory to the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters to purchase such Securities on such terms.&nbsp;If other
persons become obligated or agree to purchase the Securities of a defaulting Underwriter, either the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters or the Company may postpone the Closing Date for up to five full business days
in order to effect any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement and the Prospectus or in any other document or arrangement, and the Company agrees to
promptly prepare any amendment or supplement to the Registration Statement and the Prospectus that effects any such changes.&nbsp;As used in this Agreement, the term &#147;Underwriter&#148; includes, for all purposes of this Agreement unless the
context otherwise requires, any person not listed in Schedule 1 hereto that, pursuant to this Section&nbsp;10, purchases Securities that a defaulting Underwriter agreed but failed to purchase. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate principal amount of such Securities that remains unpurchased does not exceed
<FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate principal amount of all the Securities, then the Company shall have the right to require each <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter to purchase the
principal amount of Securities that such Underwriter agreed to purchase hereunder plus such Underwriter&#146;s pro rata share (based on the principal amount of Securities that such Underwriter agreed to purchase hereunder) of the Securities of such
defaulting Underwriter or Underwriters for which such arrangements have not been made. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If, after giving effect to any arrangements for
the purchase of the Securities of a defaulting Underwriter or Underwriters by the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate principal amount of such
Securities that remains unpurchased exceeds <FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate principal amount of all the Securities, or if the Company shall not exercise the right described in paragraph (b)&nbsp;above, then this
Agreement shall terminate without liability on the part of the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters.&nbsp;Any termination of this Agreement pursuant to this Section&nbsp;10 shall be without liability on the part of the
Company, except that the Company will continue to be liable for the payment of expenses as set forth in Section&nbsp;11 hereof and except that the provisions of Section&nbsp;7 hereof shall not terminate and shall remain in effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter for damages caused by its default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Payment of
Expenses</U>.&nbsp;(a)&nbsp;Whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Company will pay or cause to be paid all costs and expenses incident to the performance of its
obligations hereunder, including without limitation, (i)&nbsp;the costs incident to the authorization, issuance, sale, preparation and delivery of the Securities and any taxes payable in connection </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
therewith; (ii)&nbsp;the costs incident to the preparation, printing and filing under the Securities Act of the Registration Statement, the Preliminary Prospectus, any Issuer Free Writing
Prospectus, any Time of Sale Information and the Prospectus (including all exhibits, amendments and supplements thereto) and the distribution thereof; (iii)&nbsp;the costs of reproducing and distributing each of the Transaction Documents;
(iv)&nbsp;the fees and expenses of the Company&#146;s counsel and independent accountants; (v)&nbsp;the fees and expenses incurred in connection with the registration or qualification and determination of eligibility for investment of the Securities
under the laws of such jurisdictions as the Representatives may designate and the preparation, printing and distribution of a Blue Sky Memorandum (including the related fees and expenses of counsel for the Underwriters); (vi)&nbsp;any fees charged
by rating agencies for rating the Securities; (vii)&nbsp;the fees and expenses of the Trustee and any paying agent (including related fees and expenses of any counsel to such parties); (viii)&nbsp;all expenses and application fees incurred in
connection with any filing with, and clearance of the offering by, the Financial Institution Regulatory Authority; and (ix)&nbsp;all expenses incurred by the Company in connection with the Investor Presentation or any &#147;road show&#148;
presentation to potential investors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If (i)&nbsp;this Agreement is terminated pursuant to Section&nbsp;9(ii), (ii)&nbsp;the Company
for any reason fails to tender the Securities for delivery to the Underwriters or (iii)&nbsp;the Company fails to satisfy any of the conditions set forth in Section&nbsp;6, the Company agrees to reimburse the Underwriters for all <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses (including the fees and expenses of their counsel) reasonably incurred by the Underwriters in connection with this Agreement and the offering
contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Recognition of the U.S. Special Resolutions Regimes</U>.</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the
transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any
such interest and obligation, were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the event that any
Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted
to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) &#147;BHC Act Affiliate&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be interpreted in accordance with,
12 U.S.C. &#167; 1841(k). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Covered Entity&#148; means any of the following: (i)&nbsp;a &#147;covered entity&#148; as that term is
defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b); (ii) a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or (iii)&nbsp;a &#147;covered FSI&#148; as that
term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Default Right&#148; has the meaning assigned to
that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;U.S.
Special Resolution Regime&#148; means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations
promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Persons Entitled to Benefit of Agreement</U>.&nbsp;This Agreement shall inure to the benefit of and be
binding upon the parties hereto and their respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates of each Underwriter referred to in Section&nbsp;7 hereof.&nbsp;Nothing in this
Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein.&nbsp;No purchaser of Securities from any Underwriter shall be
deemed to be a successor merely by reason of such purchase. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Survival</U>.&nbsp;The respective indemnities, rights of contribution,
representations, warranties and agreements of the Company and the Underwriters contained in this Agreement or made by or on behalf of the Company or the Underwriters pursuant to this Agreement or any certificate delivered pursuant hereto shall
survive the delivery of and payment for the Securities and shall remain in full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Company or the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Certain Defined Terms</U>.&nbsp;For purposes of this Agreement, (a)&nbsp;except where otherwise expressly provided, the term
&#147;affiliate&#148; has the meaning set forth in Rule&nbsp;405 under the Securities Act; (b)&nbsp;the term &#147;business day&#148; means any day other than a day on which banks are permitted or required to be closed in New York City; and
(c)&nbsp;the term &#147;subsidiary&#148; has the meaning set forth in Rule&nbsp;405 under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.
<U>Miscellaneous</U>.&nbsp;(a)&nbsp;<I>Authority of the Representatives</I>.&nbsp;Any action by the Underwriters hereunder may be taken by the Representatives on behalf of the Underwriters, and any such action taken by the Representatives shall be
binding upon the Underwriters. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Notices</I>.&nbsp;All notices and other communications hereunder shall be in writing and shall be
deemed to have been duly given if mailed or transmitted and confirmed by any standard form of telecommunication.&nbsp;Notices to the Underwriters shall be given to the Representatives c/o Barclays Capital Inc., 745 Seventh Avenue, New York, New York
10019, Attention: Syndicate Registration, Fax: (646) <FONT STYLE="white-space:nowrap">834-8133;</FONT> Citigroup Global Markets Inc., 388 Greenwich Street, New York, New York 10013, Attention: General Counsel, Fax: (646) <FONT
STYLE="white-space:nowrap">291-1469;</FONT> and J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, Attention: Investment Grade Syndicate Desk &#150; 3rd Floor, Fax: (212) <FONT STYLE="white-space:nowrap">834-6081.</FONT>
Notices to the Company shall be given to it at Agilent Technologies,&nbsp;Inc., 5301 Stevens Creek Boulevard, Santa Clara, California 95051, (fax: (408) <FONT STYLE="white-space:nowrap">553-3417);</FONT> Attention: Treasurer, with a copy to Agilent
Technologies,&nbsp;Inc., 5301 Stevens Creek Boulevard, Santa Clara, California 95051, (fax: (408) <FONT STYLE="white-space:nowrap">345-8242);</FONT> Attention: General Counsel. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Counterparts</I>.&nbsp;This Agreement may be signed in counterparts (which may include counterparts delivered by facsimile, in portable
document format, or .pdf, or any standard form of telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Amendments or Waivers</I>.&nbsp;No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure
therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)
<I>Headings</I>.&nbsp;The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Entire Agreement</I>. This Agreement supersedes all prior agreements and understandings (whether written or oral) between or among the
Company and the Underwriters, or any of them, with respect to the subject matter hereof except for any agreement or understanding between the Company and the Underwriters with respect to the reimbursement by the Underwriters to the Company of
expenses incurred by the Company in connection with the issuance of the Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Governing Law</I>; <I>Submission to
Jurisdiction</I>. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPLES OF CONFLICT OF LAWS THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAWS OF THE
STATE OF NEW YORK. The Company agrees that any suit or proceeding arising in respect of this agreement will be tried exclusively in the U.S. District Court for the Southern District of New York or, if that court does not have subject matter
jurisdiction, in any state court located in The City and County of New York and the Company agrees to submit to the jurisdiction of, and to venue in, such courts. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Jury Trial</I>. The Company and each of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable law,
any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Compliance with USA Patriot Act</I>. In accordance with the requirements of the USA
Patriot Act (Title III of Pub. L. <FONT STYLE="white-space:nowrap">107-56</FONT> (signed into law October&nbsp;26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their respective clients, including the
Company, which information may include the name and address of their respective clients, as well as other information that will allow the Underwriters to properly identify their respective clients. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding, please indicate your acceptance
of this Agreement by signing in the space provided below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">AGILENT TECHNOLOGIES,&nbsp;INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Guillermo Gualino</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Guillermo Gualino</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Vice President and Treasurer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature
Page&nbsp;to Underwriting Agreement</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Accepted as of the date hereof</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BARCLAYS CAPITAL INC.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CITIGROUP GLOBAL MARKETS INC. and</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. MORGAN SECURITIES LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">As Representatives of the</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">several Underwriters listed</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">in Schedule 1 hereto.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BARCLAYS CAPITAL INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James Gutow</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: James Gutow</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CITIGROUP GLOBAL MARKETS INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian D. Bednarski</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Brian D. Bednarski</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. MORGAN SECURITIES LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Som Bhattacharyya</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Som Bhattacharyya</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Executive Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page&nbsp;to Underwriting Agreement] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Schedule 1 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount&nbsp;of<BR>Securities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">221,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">221,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">221,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNP Paribas Securities Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MUFG Securities Americas Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Credit Suisse Securities (USA) LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSBC Securities (USA) Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KeyBanc Capital Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Penserra Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">850,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Annex A </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Time of Sale Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Free Writing
Prospectus (consisting of a pricing term sheet substantially in the form of Annex B hereto) dated March&nbsp;3, 2021. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Annex B </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule&nbsp;433 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration No.&nbsp;333-233593 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Issuer Free Writing Prospectus dated March&nbsp;3, 2021 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Relating to Preliminary Prospectus Supplement dated March 3, 2021 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Agilent Technologies,&nbsp;Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Pricing Term Sheet </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2.300%
Senior Notes due 2031 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="65%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Issuer:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Agilent Technologies,&nbsp;Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Principal Amount:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$850,000,000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Security Type:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Senior Notes</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Maturity Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">March&nbsp;12, 2031</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Coupon:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.300%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Price to Public:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">99.822% of the principal amount</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Yield to Maturity:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.320%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Spread to Benchmark Treasury:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">+85 basis points</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Benchmark Treasury:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">1.125% due February&nbsp;15, 2031</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Benchmark Treasury Price / Yield:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">96-26</FONT> / 1.470%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Interest Payment Dates:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">March&nbsp;12 and September&nbsp;12, commencing September&nbsp;12, 2021</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Make-Whole Call:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Prior to December&nbsp;12, 2030, the greater of par and redemption price at Treasury +15 basis points</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Par Call:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">On or after December&nbsp;12, 2030</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Trade Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">March&nbsp;3, 2021</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Settlement Date*:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">March&nbsp;12, 2021 (T+7)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Denominations:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$2,000 x $1,000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CUSIP / ISIN:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">00846U AN1 / US00846UAN19</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ratings**:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Baa2 by Moody&#146;s Investors Service,&nbsp;Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BBB+ by Standard&nbsp;&amp; Poor&#146;s Ratings Services</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">BBB+ by
Fitch Ratings</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Joint Book-Running Managers:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets
Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BNP Paribas Securities
Corp.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">MUFG Securities Americas Inc.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Co-Managers:</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Credit Suisse Securities (USA) LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HSBC
Securities (USA) Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KeyBanc Capital Markets Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Penserra
Securities LLC</P></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Under Rule <FONT STYLE="white-space:nowrap">15c6-1</FONT> under the Securities Exchange Act of 1934, trades in
the secondary market are required to settle in two business days, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade notes prior to the second business day preceding the settlement date will be
required, by virtue of the fact that the notes initially settle in T+7, to specify an alternate settlement arrangement at the time of any such trade to prevent a failed settlement. Purchasers of the notes who wish to trade the notes prior to their
date of delivery hereunder should consult their advisors. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Note: A securities rating is not a recommendation to buy, sell or hold securities and is subject to revision or
withdrawal at any time. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Annex B </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication
relates.&nbsp;Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering.&nbsp;You may get these documents
for free by visiting EDGAR on the SEC website at www.sec.gov.&nbsp;Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by contacting Barclays Capital Inc.
toll-free at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-888-603-5847,</FONT></FONT></FONT> Citigroup Global Markets Inc. toll-free at <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-831-9146</FONT></FONT></FONT> or J.P. Morgan Securities LLC at
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-212-834-4533.</FONT></FONT></FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or
notice was automatically generated as a result of this communication being sent by Bloomberg or another email system. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Annex C </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor presentation of the Company used for investor meetings on March&nbsp;3, 2021. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-1 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d147637dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g147637dsp032.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">March&nbsp;5, 2021 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Agilent Technologies, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5301 Stevens Creek Boulevard </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Santa Clara, CA 95051 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Debt Securities Registered under Registration Statement on Form
<FONT STYLE="white-space:nowrap">S-3</FONT></U> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen:&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as counsel to you in connection with your filing of a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT>
(File <FONT STYLE="white-space:nowrap">No.&nbsp;333-233593)</FONT> (as amended or supplemented, the &#147;<B>Registration Statement</B>&#148;) filed on September&nbsp;3, 2019 with the Securities and Exchange Commission (the
&#147;<B>Commission</B>&#148;) pursuant to the Securities Act of 1933, as amended (the &#147;<B>Securities Act</B>&#148;), relating to the registration of the offer of debt securities (the &#147;<B>Debt Securities</B>&#148;) of Agilent Technologies,
Inc., a Delaware corporation (the &#147;<B>Company</B>&#148;) The Registration Statement became effective upon filing with the Commission on September&nbsp;3, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reference is made to our opinion letter dated September&nbsp;3, 2019 and included as Exhibit 5.1 to the Registration Statement. We are
delivering this supplemental opinion letter in connection with the prospectus supplement (the &#147;<B>Prospectus Supplement</B>&#148;) filed on March&nbsp;5, 2021 by the Company with the Commission pursuant to Rule 424 under the Securities Act. The
Prospectus Supplement relates to the offering by the Company of $850,000,000 aggregate principal amount of Debt Securities in the form of 2.300% Senior Notes due 2031 (the &#147;<B>Notes</B>&#148;). The Notes are being sold to the several
underwriters named in, and pursuant to, an underwriting agreement among the Company and such underwriters (the &#147;<B>Underwriting Agreement</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have reviewed such documents and made such examination of law as we have deemed appropriate to give the opinion set forth below. We have
relied, without independent verification, on certificates of public officials and, as to matters of fact material to the opinion set forth below, on certificates of officers of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We refer to the Supplemental Indenture, which is anticipated to be dated on or about March&nbsp;12, 2021 and entered into by the Company and
Citibank, N.A., as trustee (the &#147;<B>Trustee</B>&#148;), establishing the terms of the Notes, in a form consistent with that authorized by the Company (the &#147;<B>Supplemental Indenture</B>&#148;). The Supplemental Indenture will amend and
supplement the Indenture, which is anticipated to be dated on or about March&nbsp;12, 2021 and entered into by and between the Company and the Trustee (the &#147;<B>Base Indenture</B>&#148; and, as amended and supplemented by the Supplemental
Indenture, the &#147;<B>Indenture</B>&#148;). We refer to the Indenture and the Notes as the &#147;<B>Subject Documents</B>.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Agilent Technologies, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March 5, 2021 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 2 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In our examination of the Subject Documents and other documents relevant to the opinion set
forth below, we have assumed, without independent verification, (i)&nbsp;the genuineness of all signatures, (ii)&nbsp;the legal capacity of all natural persons, (iii)&nbsp;the authenticity and completeness of all Subject Documents submitted to us as
originals, (iv)&nbsp;the conformity to originals of any Subject Documents submitted to us as copies or by facsimile or other means of electronic transmission and (v)&nbsp;the truth, accuracy and completeness of information, representations and
warranties contained in the Subject Documents. We have assumed that the Indenture has been duly authorized by the Trustee. We have also assumed the validity and constitutionality of each relevant statute, rule, regulation and action by governmental
agencies covered by this opinion letter, unless a reported decision of a court in the relevant jurisdiction has held otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
opinion set forth below is limited to the Delaware General Corporation Law and the law of New York (without regard to the possible application under New York
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">choice-of-law</FONT></FONT> rules of the substantive law of any other jurisdiction). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the foregoing, and subject to the additional qualifications set forth below, we are of the opinion that upon the due execution and
delivery of the Indenture by each of the parties thereto and the execution, authentication and issuance of the Notes against payment therefor pursuant to the Underwriting Agreement and in accordance with the terms of the Indenture, the Notes will be
valid and binding obligations of the Company, enforceable against the Company in accordance with their terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinion set forth above
is subject to the following additional qualifications: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Our opinion set forth above as to enforceability is subject to and limited by
the effect of any applicable bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar laws of general application affecting the rights and remedies of creditors and to general principles of equity. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) We express no opinion with respect to any provision of any of the Subject Documents relating to:
<FONT STYLE="white-space:nowrap">(a)&nbsp;non-reliance,</FONT> exculpation, disclaimer, limitation of liability, indemnification, contribution, waiver, limitation or exclusion of remedies; (b)&nbsp;liquidated damages, forfeitures, default interest,
late charges, make-whole premiums, payment of attorneys&#146; fees, collection upon acceleration of amounts that might be determined to constitute unearned interest thereon, or other economic remedies, in each case to the extent it constitutes a
penalty or is prohibited by law; (c)&nbsp;concepts of materiality, reasonableness, good faith, fair dealing or unconscionability; (d)&nbsp;governing law (except for the enforceability of any provision choosing New York law as a Subject
Document&#146;s governing law pursuant to the statutes referred to in paragraph (iii)&nbsp;below); (e) the waiver of the right to trial by jury or of usury, stay, extension and similar laws; (f)&nbsp;rights or remedies not being exclusive, not
preventing the concurrent assertion of any other right or remedy, being cumulative and exercisable in addition to any other right and remedy, or any delay or omission to exercise any right or remedy not impairing any right or remedy or not
constituting a waiver thereof; (g)&nbsp;any obligation or agreement to use best efforts, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Agilent Technologies, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March 5, 2021 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 3 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reasonable best efforts or commercially reasonable efforts; (h)&nbsp;any requirement that a party take further action or enter into further agreements or instruments or provide further
assurances; (i)&nbsp;any requirement that amendments or waivers be in writing insofar as they suggest that oral or other modifications, amendments or waivers could not be effectively agreed upon by the parties or that the doctrine of promissory
estoppel might not apply; (j)&nbsp;service of process by any method not provided for under applicable statute or court rule; and (k)&nbsp;the severability of any provisions to the foregoing effect to the extent such provisions are unenforceable.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) To the extent that any opinion set forth herein relates to the enforceability of choice of New York law, choice of New York forum or
exclusive jurisdiction provisions in any of the Transaction Documents, such opinion is rendered solely in reliance upon N.Y. Gen. Oblig. Law &#167;&#167; <FONT STYLE="white-space:nowrap">5-1401,</FONT> <FONT STYLE="white-space:nowrap">5-1402</FONT>
(McKinney 2010) and N.Y. CPLR 327(b) (McKinney 2010) and is subject to the qualification that such enforceability may be limited by public policy or other considerations of any jurisdiction, other than the State of New York, in which enforcement of
such provisions, or of a judgment upon an agreement containing such provisions, is sought and by constitutional limitations. With respect to waiving any objection to venue our opinion is qualified in its entirety by N.Y. CPLR 510 (McKinney 2010). We
call your attention that courts of the State of New York, or federal courts of the United States of America located in New York, could decline to hear a case on grounds of forum non conveniens or similar doctrines limiting the availability of such
courts as a forum for the resolution of disputes, irrespective of any agreement between the parties concerning jurisdiction. We express no opinion as to (i)&nbsp;any waiver of objections based on inconvenient forum or (ii)&nbsp;venue or the subject
matter jurisdiction of the federal courts of the United States. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) Our opinion set forth above does not cover, without limitation, the
following: the Defense Production Act of 1950, as amended, and the Foreign Investment Risk Review Modernization Act of 2018, including all implementing regulations thereunder, banking, tax, antitrust, trade regulation, anti-fraud or unfair
competition laws; insolvency or fraudulent transfer; compliance with fiduciary duty requirements; pension or employee benefits; environmental or energy laws; Financial Industry Regulatory rules; stock exchange rules; consumer protection laws;
utilities laws; foreign trade, national security, anti-terrorism, anti-money laundering laws; laws regulating derivatives, investment and brokerage services; or other laws customarily understood to be excluded even though they are not expressly
stated to be excluded, except to the extent expressly covered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the inclusion of this opinion as Exhibit 5.1 to the
Company&#146;s Current Report on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form-8-K,</FONT></FONT> filed on March&nbsp;5, 2021, which is incorporated by reference into the Registration Statement and to the references to our
firm under the caption &#147;Legal Matters&#148; in the Registration Statement. In giving our consent, we do not admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and
regulations thereunder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours,</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ GOODWIN PROCTER LLP</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>d147637dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Agilent Technologies Announces Pricing of $850 Million of Senior Notes </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SANTA CLARA, Calif., March&nbsp;3, 2021&nbsp;&#150; Agilent Technologies,&nbsp;Inc. (NYSE: A) today announced the pricing of an underwritten, registered
public offering of a series of its senior notes in an aggregate principal amount of $850&nbsp;million. The offering is being conducted under an automatic shelf registration statement on file with the Securities and Exchange Commission. The notes
will mature in March&nbsp;2031 and will bear interest at an annual rate of 2.300&nbsp;percent. The offering is expected to close on March&nbsp;12, 2021, subject to the satisfaction of customary closing conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The estimated net proceeds of the offering are expected to be approximately $841.1&nbsp;million. Agilent&nbsp;intends to use the net proceeds from the
offering to fund the redemption of its 3.200% senior notes due 2022 (the &#147;2022 notes&#148;), to pay down borrowings under its commercial paper program and for general corporate purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc., Citigroup Global Markets Inc. and J.P. Morgan Securities LLC are acting as joint book-running managers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Copies of the prospectus supplement and the accompanying prospectus relating to the offering can be obtained from: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Barclays Capital Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Broadridge Financial Solutions
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1155 Long Island Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Edgewood, NY 11717 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: barclaysprospectus@broadridge.com </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Telephone: <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-888-603-5847</FONT></FONT></FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Citigroup Global
Markets Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Broadridge Financial Solutions </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1155
Long Island Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Edgewood, NY 11717 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Telephone: <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-831-9146</FONT></FONT></FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email:
prospectus@citi.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>J.P. Morgan Securities LLC </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o
Broadridge Financial Solutions </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Prospectus Department </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1155 Long Island Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Edgewood, NY 11717 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Telephone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-866-803-9204</FONT></FONT></FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Electronic copies of the prospectus supplement and accompanying prospectus are or will be available for free by visiting EDGAR on the Securities and Exchange
Commission website at www.sec.gov. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities
nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This press release also does
not constitute a notice of redemption under the indenture governing the 2022 notes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Agilent Technologies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward
improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers&#146; most challenging questions.</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This release contains &#147;forward-looking statements&#148; within the meaning of the federal securities laws, including with respect to the closing of
Agilent&#146;s senior notes offering and the anticipated use of the net proceeds therefrom, including the redemption of its 2022 notes. Forward-looking statements are typically identified by words or phrases such as &#147;will,&#148;
&#147;anticipate,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;project,&#148; &#147;intend,&#148; &#147;plan,&#148; &#147;believe,&#148; &#147;target,&#148; &#147;forecast,&#148; and other words and terms of similar meaning. These
statements are subject to significant risks and uncertainties, including, without limitation, risks and uncertainties related to economic, market or business conditions and satisfaction of customary closing conditions related to the public offering.
No assurance can be given that the securities offering discussed above will be consummated on the terms described or at all. Except as required by law, Agilent expressly disclaims any obligation to publicly revise any forward-looking statements
contained in this news release to reflect the occurrence of events after the date of this news release. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Contact: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ankur Dhingra </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 408 345 8948 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ankur_dhingra@agilent.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>a-20210303.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 3/5/2021 9:09:51 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:a="http://www.agilent.com/20210303"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.agilent.com/20210303"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="a-20210303_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="a-20210303_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>a-20210303_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 3/5/2021 9:09:51 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>a-20210303_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 3/5/2021 9:09:51 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="a-20210303.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g147637dsp032.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g147637dsp032.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MJTHX^E4T>C,:V JTM5JC?# @$<CM7=<X-A:8!0 4 % !0 4 % !0 4 % !0
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5 !0 4 % !0 4 % !0 4 % !0!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d147637d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="a-20210303.xsd" xlink:type="simple"/>
    <context id="duration_2021-03-03_to_2021-03-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001090872</identifier>
        </entity>
        <period>
            <startDate>2021-03-03</startDate>
            <endDate>2021-03-03</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2021-03-03_to_2021-03-03">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2021-03-03_to_2021-03-03"
      id="Hidden_dei_EntityCentralIndexKey">0001090872</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2021-03-03_to_2021-03-03">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2021-03-03_to_2021-03-03">2021-03-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2021-03-03_to_2021-03-03">AGILENT TECHNOLOGIES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2021-03-03_to_2021-03-03">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2021-03-03_to_2021-03-03">001-15405</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2021-03-03_to_2021-03-03">77-0518772</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2021-03-03_to_2021-03-03">5301 Stevens Creek Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2021-03-03_to_2021-03-03">Santa Clara</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2021-03-03_to_2021-03-03">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2021-03-03_to_2021-03-03">95051</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2021-03-03_to_2021-03-03">(800)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2021-03-03_to_2021-03-03">227-9770</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2021-03-03_to_2021-03-03">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2021-03-03_to_2021-03-03">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2021-03-03_to_2021-03-03">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2021-03-03_to_2021-03-03">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2021-03-03_to_2021-03-03">Common Stock, $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-03-03_to_2021-03-03">A</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-03-03_to_2021-03-03">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2021-03-03_to_2021-03-03">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139695387397160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001090872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  03,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AGILENT TECHNOLOGIES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0518772<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5301 Stevens Creek Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Santa Clara<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95051<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(800)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">227-9770<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 Par Value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M&6HQJ#=;U6-8EZ5JCS^%]RBYGQON_Q+%#U!+ P04    " #B@V52EXJ[',
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M95(<.&7J/P$  #P"   /    >&PO=V]R:V)O;VLN>&ULC5'+;L) #/R5U7Y
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M%0:P;W(@"2[)E1M27>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04
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MUDX:?^:+X3]>?P%02P$"% ,4    " #B@V52!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .*#95*)
M\ 0X[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( .*#95*97)PC$ 8  )PG   3              "  <T!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ XH-E4MEPYM! !
M1!   !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( .*#95*#J:4#U $  #(&   -              "  80,
M  !X;"]S='EL97,N>&UL4$L! A0#%     @ XH-E4I>*NQS     $P(   L
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64$L%!@     )  D /@(   <3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d147637d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d147637d8k.htm">d147637d8k.htm</File>
    <File>a-20210303.xsd</File>
    <File>a-20210303_lab.xml</File>
    <File>a-20210303_pre.xml</File>
    <File>d147637dex11.htm</File>
    <File>d147637dex51.htm</File>
    <File>d147637dex991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d147637d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d147637d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "a-20210303_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "a-20210303_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "a-20210303.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "a",
   "nsuri": "http://www.agilent.com/20210303",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d147637d8k.htm",
      "contextRef": "duration_2021-03-03_to_2021-03-03",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d147637d8k.htm",
      "contextRef": "duration_2021-03-03_to_2021-03-03",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.agilent.com//20210303/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-21-071538-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-21-071538-xbrl.zip
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M<[U(60:\YK<H2R0Z_72PVI;8&]K\\\$*623BLP_5\D*05H*L%-+G@RW:L'Q
MZ.JEN.-*;YG?@)'MHNGO@=![_@-02P,$%     @ XH-E4H(2KLBT!    "L
M !(   !A+3(P,C$P,S S7W!R92YX;6S5FEV/XC84AN]7VO_@9F]:J2%DV.D6
M-,R*,C,KU/E P+95;U8F.8!5QT:V&>#?]SC@BD"8A6FWBKF X/@]?GT>QTF<
M7'U<99P\@]),BG80U^H! 9'(E(EI.UCHD.J$L8!H0T5*N130#M:@@X_7;]]<
M?1>&Y.:N]TA",C-FKEM1M%PN:^F$"2WYPF!(74MD%I$P=/6[H\_DMTUS+3(
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M8GJQ9@%?:#_);2U4*EJ !,>KS"K)-U>LXICWMVK@IZ#>CVQ,DP&7VLU*096
MYK?E8VJYX:,8+0^#?J#,4AE*W)IKJ 73=!(0'>AL/X"P'EGVJE]K*5)[NCH-
MW!".4(#I]$00Y\O:ED#I<\ [AI/ 2!H$HV%UR,B4\88 3A2IPKUPO-8"NGF"
M",^^W*5+[A*=B=4;W[RH' /D<5:N%X)7!J(>!Y%%Q!?._7O8P:7@8$X$>)^7
M 'U(-5*L!.E!@<HF026-'^<SCN&LOX'X4#,.%E4*U)NQ4)8%R,Z#1-=EC"LI
MGZ?WIA&[)$PI2H6Q9B36%>> 5X8>"!@*L%->*BUHYXP"*^"M1HJD*\YA!*Z
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M/P^C49).WYPGH[@,/L77P6D^BN!-N\=''S[]]5F17%S"JW[=>W?X[3+I)54
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ME\P_Z0!L_SP /_X!Z#:XGH3T;\.!'"1EGCTIY;_YLJ'\[]T!.(9YPV_0YOX
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MQ1K&OUBM1W:R^:V6-[@>W&W/CS,?+2?]RV!100N-9NRC43B*IB!S;,1$WB&
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MY?:TKF[XA,W.Y:4GY)[=N]DY<QM]_;;0/OX #E^[(8O/5$NPO'1+47Y\[W!
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MXD<4Y#J5:/=F/W[&+K6ZSMV*-66GKLNZ>;J@H.#)9DGA0E.DTJ ,?&C0]+X
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MFZ]W-F:02+='.-RYFT\DK9MLU =@*D,?7Z2_L1.,S:);\QAWX(M8/*.QN$]
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MR\GP3\7RDB>M@92A2[A(\<9S5TS_1/E?)<^M+H.A2!]HKZ1T!=TF9*=ZJOS
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MP-EV(;NB%JWS4Q:(=_<ZO,58/5[D6=(/D(H^*"\)!NZ[U/C!KM6P@VM9<18
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M8 "D;<65H?WC4H'[W>TE0?++AN"8%S^%G&NDB-C<)''@( >ZLS+I=E@<]Z!
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M_O_&WO\;>U]H[.W^J8V];Z*7SK5"YFEY*KER9&8SBB8R21:-#!6&( Q,&V'
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MF&86BH!MJL::WJITKJU)P]5)0J'*3A:>EG<ZQ2[:W:D!7]AAX%@"]')G-P>
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MT9K4%7D?AY?W'O4O1N^O3OH7P\'Y2;W6'UV.KH8GPW\T#P];G?YV,<3\=BG
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M([6YBMCP2SCA*A;L3*>IM':NA+>B7IM",435Y4:024NAV&GO=OP27B00W$"
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M+3(P,C$P,S S+GAS9%!+ 0(4 Q0    ( .*#95*$'BN88 8  $=$   2
M          "  8D#  !A+3(P,C$P,S S7VQA8BYX;6Q02P$"% ,4    " #B
M@V52@A*NR+0$    *P  $@              @ $9"@  82TR,#(Q,#,P,U]P
M<F4N>&UL4$L! A0#%     @ XH-E4DY9ZYKR$@  3G    X
M ( !_0X  &0Q-#<V,S=D.&LN:'1M4$L! A0#%     @ XH-E4F41;R)H=0
MQ6," !               ( !&R(  &0Q-#<V,S=D97@Q,2YH=&U02P$"% ,4
M    " #B@V52NYJ:! H2  !U/   $               @ &QEP  9#$T-S8S
M-V1E>#4Q+FAT;5!+ 0(4 Q0    ( .*#95+<1:4'V @  /P?   1
M      "  >FI  !D,30W-C,W9&5X.3DQ+FAT;5!+!08     !P ' +,!  #P
%L@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
